**Exhibit
      31**





Certifications





I,
      Dr.
      Ramesh Zacharias, certify that:





1.
      I
      have reviewed this quarterly report on Form 10-Q of Med-Emerg International
      Inc.;





2.
      Based on my knowledge, this quarterly report does not contain any untrue
      statement of a material fact or omit to state a material fact necessary to
      make
      the statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this quarterly
      report;





3.
      Based on my knowledge, the financial statements, and other financial information
      included in this quarterly report, fairly present in all material respects
      the
      financial condition, results of operations and cash flows of the registrant
      as
      of, and for, the periods presented in this quarterly report;





4.
      The
      registrant's other certifying officers and I are responsible for establishing
      and maintaining disclosure controls and procedures (as defined in Exchange
      Act
      Rules 13a-14 and 15d-14) for the registrant and we have:





a)
      designed such
      disclosure controls and procedures to ensure that material information relating
      to the registrant, including its consolidated subsidiaries, is made known to
      us
      by others within those entities, particularly during the period in which this
      quarterly report is being prepared;





b)
      evaluated the
      effectiveness of the registrant's disclosure controls and procedures and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this
      report based on such evaluation; and





c)
      disclosed in this
      quarterly report any change in the registrant’s internal control over financial
      reporting that occurred during the registrant’s third fiscal quarter that has
      materially affected, or is reasonably likely to materially affect, the
      registrant’s internal control over financial reporting.





5.
      The
      registrant's other certifying officers and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      registrant's auditors and the audit committee of registrant's board of directors
      (or persons performing the equivalent functions):





a)
      all significant
      deficiencies and material weaknesses in the design or operation of internal
      control over financial reporting which are reasonably likely to adversely affect
      the registrant’s ability to record, process, summarize and report financial
      information; and





b)
      any fraud, whether
      or not material, that involves management or other employees who have a
      significant role in the registrant's internal control over financial
      reporting.





Date: 
      November 14, 2005






Dr.
                Ramesh ZachariasChief
                Executive Officer













I,
        William Danis, certify that:
 
 1.
        I
        have reviewed this quarterly report on Form 10-Q of Med-Emerg International
        Inc.;
 
 2.
        Based on my knowledge, this quarterly report does not contain any untrue
        statement of a material fact or omit to state a material fact necessary to
        make
        the statements made, in light of the circumstances under which such statements
        were made, not misleading with respect to the period covered by this quarterly
        report;
 
 3.
        Based on my knowledge, the financial statements, and other financial information
        included in this quarterly report, fairly present in all material respects
        the
        financial condition, results of operations and cash flows of the registrant
        as
        of, and for, the periods presented in this quarterly report;
 
 4.
        The
        registrant's other certifying officers and I are responsible for establishing
        and maintaining disclosure controls and procedures (as defined in Exchange
        Act
        Rules 13a-14 and 15d-14) for the registrant and we have:
 
 a)
        designed such disclosure controls and procedures to ensure that material
        information relating to the registrant, including its consolidated subsidiaries,
        is made known to us by others within those entities, particularly during
        the
        period in which this quarterly report is being prepared;
 
 b)
        evaluated the effectiveness of the registrant's disclosure controls and
        procedures and presented in this report our conclusions about the effectiveness
        of the disclosure controls and procedures, as of the end of the period covered
        by this report based on such evaluation; and
 
 c)
        disclosed in this quarterly report any change in the registrant’s internal
        control over financial reporting that occurred during the registrant’s third
        fiscal quarter that has materially affected, or is reasonably likely to
        materially affect, the registrant’s internal control over financial
        reporting.
 
 5.
        The
        registrant's other certifying officers and I have disclosed, based on our
        most
        recent evaluation of internal control over financial reporting, to the
        registrant's auditors and the audit committee of registrant's board of directors
        (or persons performing the equivalent functions):
 
 a)
        all
        significant deficiencies and material weaknesses in the design or operation
        of
        internal control over financial reporting which are reasonably likely to
        adversely affect the registrant’s ability to record, process, summarize and
        report financial information; and
 
 b)
        any
        fraud, whether or not material, that involves management or other employees
        who
        have a significant role in the registrant's internal control over financial
        reporting.
 
 Date: 
        November 14, 2005
  William
                    DanisChief
                    Financial Officer